Gregory Tsay (Taiwan) suggested that RNA interference targeting IL-10 is an effective www.selleckchem.com/products/VX-770.html strategy to silence the IL-10 pathway and has therapeutic potential that could be useful in the management of
SLE and possibly other immune-mediated disorders. Chetan Chitnis (India) and Nirbhay Kumar (USA) presented their research work which is moving towards the development of a vaccine against malaria. Sunil Arora (India) highlighted one of the reasons for the success of antiviral therapy in chronic hepatitis C infection which relates to the functional status of myeloid dendritic cells (mDCs) in these patients. The sixth symposium covered the broad theme of autoimmunity, featuring discussions on the genetic and functional aspects of autoimmune diseases. Chella David (USA) and Kamal Moudgil (USA) unraveled novel aspects of autoimmune pathogenesis. The role of complement in RA and SLE, with a main focus on B-cell functions, was highlighted by Anna Erdei (Hungary). Veena Taneja (USA) described the importance of the interaction between the HLA gene products and gut microbes in the development selleck inhibitor of rheumatoid arthritis. Moncef Zouali
(France) and Rahul Pal (India) gave an overview of new pathways and new targets in autoimmune diseases. The theme-based symposium of the last day of the Congress featured talks on immune mechanisms underlying infectious diseases. In this session, Miles Davenport (Australia) explained that the CD8+ T-cell response to Rucaparib supplier viral infection involves the recruitment of multiple different T-cell clonotypes, each bearing a unique T-cell receptor. Nageshwar Rao (India) discussed the mechanism leading to immune suppression during the progression of leprosy from tuberculoid to lepromatous, namely the overproduction of CD4+CD25+/FoxP3+ cells. Padmini Salgame (USA) showed that the T helper and regulatory response induced by helminths could modulate the host protective response against M. tuberculosis. Suresh Mahalingam (Australia) highlighted the link between viral infections and inflammatory disease focusing on the Chikungunia virus. Symposium 8 started with a theme focused on infections, immunodeficiencies and HIV. The first
speaker of this symposium, Rose Ffrench (Australia), presented data on the production of interferon-lambda in chronic HCV infection. This was followed by Gurvinder Kaur (India) who discussed the genetic architecture of HIV infection particularly in relation to disease susceptibility, progression and transmission. Gurvinder Kaur’s lecture focused on three sets of immuno-regulatory molecules and their genetic polymorphisms, namely HLA, chemokines and cytokine gene polymorphisms. Stanley Schwartz (USA) linked the application of nanotechnology to HIV infection and Madhu Vajpayee (India) discussed the abnormal behavior of T cells in HIV. Ashok Kumar (USA) and Nirupama Trehanpati (India) focused on the immunology of ocular infectious disease and HBV infection in newborns respectively.